Peer reviewed
Tirzepatide as compared with semaglutide for the treatment of obesity
Head-to-head randomized SURMOUNT-5 obesity trial.
New England Journal of MedicinePublished 2025Accessed 2026-07-12
Registry record
Source metadata
- Publisher
- New England Journal of Medicine
- Source type
- Peer reviewed
- Registry ID
nejm-surmount5-tirzepatide-semaglutide
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.